© Universität Bielefeld
Tumour Targeting
Cryptophycins are a class of 16-membered highly cytotoxicmacrocyclic depsipeptides isolated from cyanobacteria. The biological activity is based on their ability to interact with tubulin. They interfere with microtubule dynamics and preventmicrotubules from forming correctmitotic spindles,which causes cell-cycle arrest and apoptosis. Their strong antiproliferative activities with 100-fold to 1000-fold potency compared with those of paclitaxel and vinblastine have been observed. Cryptophycins are highly promising drug candidates, as their biological activity is not negatively affected by P-glycoprotein, a drug efflux systemcommonly found in multidrug-resistant cancer cell lines and solid tumors. Cryptophycin-52 had been investigated in phase II clinical trials but failed because of its high neurotoxicity. Recently, cryptophycin conjugates with peptides and antibodies have been developed for targeted delivery in tumor therapy.
Cedric Dessin
Room: F2-264
Telephone: +49 (0) 521 106 2147
E-Mail: cedric.dessin@uni-bielefeld.de
Waldemar Meiser
Room: F2-207
Telephone: +49 (0) 521 106 2152
E-Mail: w.meiser@uni-bielefeld.de
Jannik Paulus
Room: F2-246
Telephone: +49 (0) 521 106 2145
E-Mail: j.paulus@uni-bielefeld.de
Thomas Schachtsiek
Room: F2-264
Telephone: +49 (0) 521 106 2147
E-Mail: t.schachtsiek@uni-bielefeld.de
Maria Walger
Room: F2-207
Telephone: +49 (0) 521 106 2152
E-Mail: mwalger@uni-bielefeld.de